A detailed history of Virtus ETF Advisers LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 5,554 shares of ITOS stock, worth $58,317. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,554
Previous 8,046 30.97%
Holding current value
$58,317
Previous $109,000 24.77%
% of portfolio
0.04%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.33 - $18.09 $25,742 - $45,080
-2,492 Reduced 30.97%
5,554 $82,000
Q1 2024

May 15, 2024

SELL
$9.89 - $13.64 $5,439 - $7,502
-550 Reduced 6.4%
8,046 $109,000
Q4 2023

Feb 15, 2024

BUY
$8.57 - $11.06 $13,112 - $16,921
1,530 Added 21.65%
8,596 $94,000
Q3 2023

Nov 07, 2023

SELL
$10.95 - $14.6 $7,741 - $10,322
-707 Reduced 9.1%
7,066 $77,000
Q2 2023

Aug 14, 2023

BUY
$12.93 - $18.05 $38,673 - $53,987
2,991 Added 62.55%
7,773 $102,000
Q1 2023

May 15, 2023

SELL
$13.02 - $22.62 $23,930 - $41,575
-1,838 Reduced 27.76%
4,782 $65,000
Q4 2022

Feb 14, 2023

BUY
$17.77 - $21.6 $14,073 - $17,107
792 Added 13.59%
6,620 $129,000
Q3 2022

Nov 14, 2022

BUY
$18.6 - $27.25 $706 - $1,035
38 Added 0.66%
5,828 $111,000
Q2 2022

Aug 12, 2022

BUY
$16.57 - $35.1 $26,992 - $57,177
1,629 Added 39.15%
5,790 $119,000
Q1 2022

May 16, 2022

SELL
$31.92 - $47.45 $8,011 - $11,909
-251 Reduced 5.69%
4,161 $134,000
Q4 2021

Feb 14, 2022

SELL
$26.23 - $47.86 $87,057 - $158,847
-3,319 Reduced 42.93%
4,412 $205,000
Q3 2021

Nov 15, 2021

SELL
$23.91 - $29.58 $9,635 - $11,920
-403 Reduced 4.95%
7,731 $209,000
Q2 2021

Aug 10, 2021

SELL
$17.9 - $36.1 $35,048 - $70,683
-1,958 Reduced 19.4%
8,134 $209,000
Q1 2021

May 17, 2021

BUY
$30.86 - $44.2 $5,431 - $7,779
176 Added 1.77%
10,092 $345,000
Q4 2020

Feb 12, 2021

BUY
$21.59 - $33.95 $214,086 - $336,648
9,916 New
9,916 $335,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $374M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.